عبير محمد راوى عبد المنعم
أستاذ
Influence of Vitamin D Status and VDR Gene Polymorphism on COVID-19 Susceptibility and Outcome
• 2024
معلومات البحث
المؤلفون
Amal Ahmed Mohamed1
, Nivin Naeem Baiomy2
, Abeer M. Rawy3
, Mona Mostafa
Farid Ghanem4
, Soha M. Abd El Salam5
,
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
Local
رابط البحث
Not Available
المواد المرفقة
Abeer Mohamed Rawy Abdel- Monem_paper 6.pdf
الملخص
Abstract
Insufficient vitamin D levels in the bloodstream, together with the presence of specific genetic variations
known as single nucleotide polymorphisms (SNPs) within the VDR gene, have consistently been linked
to a higher likelihood of contracting and experiencing more severe forms of various diseases such as
the ongoing COVID-19 pandemic. We aimed to explore the potential connection between vitamin D
levels, Bsml and FOKI polymorphisms, and COVID-19 infection outcomes. A case-control study was
conducted with COVID-19 patients and a control group of non-COVID-19 patients (n = 107 each). The
associations between vitamin D status, polymorphisms, and COVID susceptibility were investigated.
Participants diagnosed with COVID-19 exhibited an average age of 48.84 ± 12.18, while non-COVID-19
patients had an average age of 46.82 ± 9.903. Disease severity, assessed by the CT severity score,
showed negative correlation with the Vitamin D levels. Among participants with COVID-19, the mean
level of vitamin D was 35.25 ± 9.40 ng/mL while non-COVID-19 patients showed 38.85 ± 9.40 ng/mL
with a significant difference (p = 0.004**) although among COVID-19 cases, 87 (81.3%) individuals
had sufficient vitamin D levels and non severity of disease was more i.e. 54 (50.5%) among the COVID
patients who had sufficient level of Vitamin D. The study found no significant association between
Vitamin D levels and rs1544410 Bsml polymorphism (p = 0.429). However, it is important to highlight
a weak significant association observed between with Fok1 polymorphism (p = 0.049). These findings
underscore the weak influence of genetic factors, particularly VDR Fok1 gene variants, in shaping
an individual’s susceptibility to COVID-19. A significant difference in vitamin D status was observed
between the COVID-19 and non-COVID-19 groups and lower level was observed in the COVID-19 infected
patients. Furthermore, a weak significant association was observed between Fok1 rs2228570 genotype
and COVID-19 susceptibility. Larger sample sizes are warranted to comprehensively understand the
association between different genotypes and COVID-19 outcomes.
Insufficient vitamin D levels in the bloodstream, together with the presence of specific genetic variations
known as single nucleotide polymorphisms (SNPs) within the VDR gene, have consistently been linked
to a higher likelihood of contracting and experiencing more severe forms of various diseases such as
the ongoing COVID-19 pandemic. We aimed to explore the potential connection between vitamin D
levels, Bsml and FOKI polymorphisms, and COVID-19 infection outcomes. A case-control study was
conducted with COVID-19 patients and a control group of non-COVID-19 patients (n = 107 each). The
associations between vitamin D status, polymorphisms, and COVID susceptibility were investigated.
Participants diagnosed with COVID-19 exhibited an average age of 48.84 ± 12.18, while non-COVID-19
patients had an average age of 46.82 ± 9.903. Disease severity, assessed by the CT severity score,
showed negative correlation with the Vitamin D levels. Among participants with COVID-19, the mean
level of vitamin D was 35.25 ± 9.40 ng/mL while non-COVID-19 patients showed 38.85 ± 9.40 ng/mL
with a significant difference (p = 0.004**) although among COVID-19 cases, 87 (81.3%) individuals
had sufficient vitamin D levels and non severity of disease was more i.e. 54 (50.5%) among the COVID
patients who had sufficient level of Vitamin D. The study found no significant association between
Vitamin D levels and rs1544410 Bsml polymorphism (p = 0.429). However, it is important to highlight
a weak significant association observed between with Fok1 polymorphism (p = 0.049). These findings
underscore the weak influence of genetic factors, particularly VDR Fok1 gene variants, in shaping
an individual’s susceptibility to COVID-19. A significant difference in vitamin D status was observed
between the COVID-19 and non-COVID-19 groups and lower level was observed in the COVID-19 infected
patients. Furthermore, a weak significant association was observed between Fok1 rs2228570 genotype
and COVID-19 susceptibility. Larger sample sizes are warranted to comprehensively understand the
association between different genotypes and COVID-19 outcomes.